Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2001-6-1
pubmed:abstractText
The occurrence of mania during antidepressant treatment is a key issue in the clinical management of bipolar disorder (BP). The serotonin transporter (5-HTT) is the selective site of action of most proserotonergic compounds used to treat bipolar depression. The 5-HTT gene (SLC6A4) has 2 known polymorphisms. The aim of this study was to investigate the role of the SLC6A4 variants in the pathogenesis of antidepressant-induced mania in BP.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0003-990X
pubmed:author
pubmed:issnType
Print
pubmed:volume
58
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
539-44
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed-meshheading:11386982-Adult, pubmed-meshheading:11386982-Antidepressive Agents, pubmed-meshheading:11386982-Bipolar Disorder, pubmed-meshheading:11386982-Carrier Proteins, pubmed-meshheading:11386982-Community-Acquired Infections, pubmed-meshheading:11386982-Female, pubmed-meshheading:11386982-Gene Frequency, pubmed-meshheading:11386982-Genotype, pubmed-meshheading:11386982-Humans, pubmed-meshheading:11386982-Male, pubmed-meshheading:11386982-Membrane Glycoproteins, pubmed-meshheading:11386982-Membrane Transport Proteins, pubmed-meshheading:11386982-Mental Disorders, pubmed-meshheading:11386982-Nerve Tissue Proteins, pubmed-meshheading:11386982-Polymorphism, Genetic, pubmed-meshheading:11386982-Retrospective Studies, pubmed-meshheading:11386982-Serotonin, pubmed-meshheading:11386982-Serotonin Agents, pubmed-meshheading:11386982-Serotonin Plasma Membrane Transport Proteins, pubmed-meshheading:11386982-Tandem Repeat Sequences
pubmed:year
2001
pubmed:articleTitle
The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings.
pubmed:affiliation
Neurogenetics Section, R-31, Centre for Addiction and Mental Health, Clarke Site, 250 College St, Toronto, Ontario, Canada M5T 1R8. James_Kennedy@CAMH.net
pubmed:publicationType
Journal Article